2.50Open2.50Pre Close0 Volume469 Open Interest10.00Strike Price0.00Turnover85.63%IV11.66%PremiumDec 20, 2024Expiry Date1.51Intrinsic Value100Multiplier28DDays to Expiry0.99Extrinsic Value100Contract SizeAmericanOptions Type-0.7150Delta0.1717Gamma4.72Leverage Ratio-0.0115Theta-0.0049Rho-3.37Eff Leverage0.0079Vega
Monte Rosa Therapeutics Stock Discussion
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
No comment yet